Amanta Healthcare disclosed off-market share transfers involving a promoter and a member of the promoter group. The transactions, executed on June 30, 2026, were conducted through an inter-se transfer mechanism. The company submitted the required disclosures to the stock exchanges on July 1, 2026, under Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Transaction Details

The disclosures were submitted in Form C by Shri Bhavesh Girishbhai Patel, a Promoter, and Shri Kirit Ambalal Desai, a Member of the Promoter Group. The transfer involved 1,000 equity shares with a total transaction value of ₹1,60,000. The mode of acquisition and disposal was specified as an inter-se transfer between the promoter and the promoter group member.

Shareholding Changes

Following the transaction, the shareholding details of the individuals were updated. Bhavesh Girishbhai Patel increased his holding through a purchase, while Kirit Ambalal Desai reduced his stake through a sale. The specific changes in their holdings are detailed below:

Compliance and Disclosure

The company confirmed that no trading in derivatives was executed by the individuals involved in the transaction. The disclosures were signed and submitted by the respective individuals on June 30, 2026, in Ahmedabad. The company secretary and compliance officer, Nikhita Dinodia, forwarded the details to BSE Limited and National Stock Exchange of India Limited for record-keeping purposes.

Jitendrakumar Jashbhai Patel, a member of the promoter group, has increased his stake in Amanta Healthcare Limited by acquiring 16,200 equity shares through open market purchases. The transactions were executed on the National Stock Exchange (NSE) between June 16 and June 18, 2026, at a total value of Rs. 24,29,680. This disclosure was submitted to the exchanges in compliance with Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Transaction Details

The acquisition was carried out via market purchase, as detailed in Form C submitted by the company. The shares were bought over a three-day period, with the intimation reaching the company on June 19, 2026. The value of the transaction excludes taxes, brokerage, and other associated charges.

Shareholding Pattern

Prior to the acquisition, Jitendrakumar Jashbhai Patel held 34,85,838 equity shares, accounting for 8.98% of the paid-up share capital. Following the purchase of 16,200 shares, his total holding has risen to 35,02,038 equity shares, which now constitutes 9.02% of the company's equity.

The filing confirmed that there were no trading activities in derivatives by the promoter group member during this period.